Usefulness of B-Type Natriuretic Peptide and C-Reactive Protein in Predicting the Presence or Absence of Left Ventricular Hypertrophy in Patients With Systemic Hypertension
- 15 January 2006
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (2) , 249-252
- https://doi.org/10.1016/j.amjcard.2005.08.028
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- C-Reactive Protein and the Risk of Developing HypertensionJAMA, 2003
- Relation of Left Ventricular Hypertrophy to Inflammation and Albuminuria in Adults With Type 2 DiabetesDiabetes Care, 2003
- 2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*Journal Of Hypertension, 2003
- Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic DysfunctionJAMA, 2002
- Reliability of echocardiographic assessment of left ventricular structure and function: The PRESERVE studyJournal of the American College of Cardiology, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy.Circulation, 1990
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsPublished by Elsevier ,1986
- Electrocardiographic detection of left ventricular hypertrophy: Development and prospective validation of improved criteriaJournal of the American College of Cardiology, 1985